Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PTGES | O14684 | 2/20 | 0.39 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | RORA | P35398 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | RORB | Q92753 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
| ▸ | KIT | P10721 | 1/20 | 0.31 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | KDR | P35968 | 1/20 | 0.31 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20826117 | 1.00 | KCNH2 (0.39) | KCNH2PTGESHTR1DPGRRORA | |
| SCHEMBL20826233 | 0.95 | PTGES (0.42) | KCNH2PTGESHTR1DPGRRORA | |
| SCHEMBL20825696 | 0.95 | PTGES (0.42) | KCNH2PTGESHTR1DPGRRORA | |
| SCHEMBL20826221 | 0.91 | PTGES (0.41) | KCNH2PTGESKIF11SERPINE1CASR | |
| SCHEMBL21944398 | 0.90 | PTGES (0.35) | KCNH2PTGESHTR1DLCKKIT | |
| SCHEMBL20825932 | 0.88 | PTGES (0.38) | KCNH2PTGESHTR1DPGRRORA | |
| SCHEMBL20825917 | 0.86 | PTGES (0.35) | PTGESMAPTNPC1RAB9A | |
| SCHEMBL20825698 | 0.86 | PTGES (0.44) | KCNH2PTGESKIF11SERPINE1CASR | |
| SCHEMBL21944402 | 0.85 | PTGES (0.38) | KCNH2PTGESHTR1DLCKKIT | |
| SCHEMBL18267242 | 0.85 | PTGES (0.39) | KCNH2PTGESPGRRORARORC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793074-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2023-10-17 | — | — | US | disclosed |
| US-11793074-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20210057653-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CANON KK (JP) | 2021-02-25 | — | — | US | disclosed |
| US-10868260-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2020-12-15 | — | — | US | disclosed |
| US-20190088885-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793074-B2 | Organic compound and photoelectric conversion element | CRY1, CYP1A1, CCNE2 | KCNH2 83/4885PTGES 3027/4885HTR1D 2302/4885 |
| US-20210057653-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CRY1, CYP1A1, CCNE2 | KCNH2 83/4885PTGES 3027/4885HTR1D 2302/4885 |
| US-10868260-B2 | Organic compound and photoelectric conversion element | CRY1, CYP1A1, CCNE2 | KCNH2 83/4885PTGES 3027/4885HTR1D 2302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.